Hematology

Acute Myeloid Leukemia (AML) Resource Guide

At a Glance

Acute Myeloid Leukemia (AML) is an aggressive blood cancer that requires rapid medical intervention. This guide helps newly diagnosed patients understand essential tests like bone marrow biopsies, decode genetic mutations, and prepare for treatment.

Welcome to the Acute Myeloid Leukemia (AML) Resource Guide. If you or a loved one has recently been diagnosed, you are likely feeling overwhelmed by the speed and complexity of the medical system. This guide is designed to help you understand the disease, decipher your medical reports, and partner effectively with your care team.

Every claim in this guide is backed by current medical research, but this resource is not a substitute for medical advice. Its purpose is to equip you with the knowledge and vocabulary you need to ask the right questions and advocate for your best possible care.

This guide is broken down into eight distinct sections. We recommend starting with the orientation, but you can jump directly to the section most relevant to your current situation by clicking the links below.

Navigating Your Diagnosis

Validation & Orientation: Understanding an AML Diagnosis

Learn what an Acute Myeloid Leukemia (AML) diagnosis means. Understand why it's a medical emergency, key symptoms, and how genetic testing guides treatment.

Symptoms & Warning Signs

Learn the early symptoms and warning signs of Acute Myeloid Leukemia (AML). Understand how low blood counts cause fatigue, bruising, and severe infections.

Understanding the Disease

Biology & Diagnosis

Learn how acute myeloid leukemia (AML) is diagnosed. Understand bone marrow biopsies, blast cell percentages, flow cytometry, and the two-hit hypothesis.

Pathology & Genetic Subtypes

Learn how to read your AML pathology report. Understand the 4 pillars of testing, ELN risk categories, and key genetic mutations like FLT3, NPM1, and TP53.

Advanced Risk Stratification (ELN Guidelines)

Learn about Acute Myeloid Leukemia (AML) risk stratification using the ELN 2022 guidelines. Understand favorable, intermediate, and adverse risk groups.

Treatment and Beyond

Standard of Care Treatment

Learn the standard treatments for acute myeloid leukemia (AML). Understand induction therapy, the 7+3 regimen, consolidation phases, and targeted drug options.

Building Your Care Team

Learn how to build your acute myeloid leukemia (AML) care team. Understand why specialized cancer centers matter and how to prepare for your first visit.

Survivorship & Monitoring for Relapse

Learn what to expect during AML survivorship. Understand how doctors monitor for relapse using MRD testing, manage late effects like cardiotoxicity, and more.

Common questions in this guide

Why is a bone marrow biopsy necessary for an AML diagnosis?

A bone marrow biopsy is essential for officially diagnosing AML and identifying the specific genetic mutations driving your disease. This detailed pathology information allows your doctors to choose the most effective treatment plan.

What do FLT3 and NPM1 mean on my pathology report?

FLT3 and NPM1 are key driver mutations found during the genetic testing of leukemia cells. Identifying these specific genetic subtypes helps your medical team predict your prognosis and select targeted therapies using established ELN guidelines.

What are the warning signs of an AML medical emergency?

A sudden onset of neutropenic fever is a true medical emergency for AML patients. Because the disease severely weakens your immune system, you must seek immediate medical attention if you develop a fever or signs of an infection.

Why do I need a primary caregiver during AML treatment?

Because AML treatment moves quickly and requires frequent hospital visits, a primary caregiver is vital. They help organize complex medical information, provide emotional support, and communicate with your care team during your treatment phases.

Curated prompts to bring to your next appointment.

1.Given my overall health, what is the most realistic primary goal for my treatment right now?
2.Who is the main point of contact on my care team if I have a question or an emergency after hours?
3.Can you provide me with a printed copy of my full pathology report and genetic testing results for my records?
4.What are the most urgent risks I face in the next 72 hours, and what signs should I look out for?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

This guide provides an educational overview of Acute Myeloid Leukemia. It is not a substitute for professional medical advice; always consult your hematologist or oncologist for guidance specific to your diagnosis and treatment.

Get notified when new evidence is published on Acute myeloid leukemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents